Skip to main content
. Author manuscript; available in PMC: 2015 Apr 28.
Published in final edited form as: JAMA. 2014 Feb 12;311(6):579–586. doi: 10.1001/jama.2013.285141

Table 2. Development of End-Stage Renal Disease in Subgroups of Live Kidney Donors in the United States, 1994-2011.

No. of Donors Cases of ESRD Cumulative Incidence of ESRD at 15 Years per 10 000 (95% CI)
All donorsa 96 217 99 30.8 (24.3-38.5)
Age at donation, y
 18-39 46 344 50 29.4 (21.4-40.2)
 40-49 28 994 17 17.4 (10.1-30.0)
 50-59 16 840 25 54.6 (34.8-85.4)
 ≥60 4039 7 70.2 (30.4-161.8)
Sex
 Women 56 775 42 21.1 (14.9-29.9)
 Men 39 442 57 44.1 (32.9-59.1)
Race
 White/other 71 769 50 22.7 (15.6-30.1)
 Black 12 387 36 74.7 (47.8-105.8)
 Hispanic 12 061 13 32.6 (17.9-59.1)
Relationship to recipientb
 Biological 64 897 83 34.1 (26.9-43.3)
 Nonbiological 31 081 16 15.1 (08.7-26.3)
a

In a mean (SD) of 8.6 (3.6) years after donation, 99 donors who were aged 50 (13) years developed end-stage renal disease (ESRD).

b

Relationship to recipient was missing for 0.25% of the records between 1994-2011.

HHS Vulnerability Disclosure